z-logo
open-access-imgOpen Access
CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells
Author(s) -
Tengfei Bian,
Abderrahmane Tagmount,
Chris D. Vulpe,
Kavitha C. Vijendra,
Chengguo Xing
Publication year - 2020
Publication title -
molecular pharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.469
H-Index - 198
eISSN - 1521-0111
pISSN - 0026-895X
DOI - 10.1124/mol.119.118745
Subject(s) - multiple drug resistance , derivative (finance) , cancer , chemistry , biology , drug resistance , microbiology and biotechnology , business , genetics , finance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom